Drug patents opposed in 2017
Drug patents opposed in 2017 at the European Patent Office (EPO)
| Patent Number | Patent Title | Company | Recent Opposition Date | Recent Opposition By | Activity Alert |
|---|---|---|---|---|---|
| EP2999752B1 | Metallic Lustre Pigments Based On Substrate Flakes With A Thickness Of 1-50 Nm | SCHLENK METALLIC PIGMENTS |
29 Dec, 2017
|
ECKART
(and 1 more)
| |
| EP2664343B2 | Suppression Of Cancer | IPSEN BIOINNOVATION |
28 Dec, 2017
|
ALLERGAN
| |
| EP1663297B2 | Hemostatic Compositions Containing Sterile Thrombin | ETHICON |
22 Dec, 2017
|
BAXTER
| |
| EP2854768B1 | Pharmaceutical Compositions Of Pemetrexed | FRESENIUS KABI ONCOLOGY |
22 Dec, 2017
|
COOKE
(and 2 more)
| |
| EP2762140B1 | Treatment Of Solid Brain Tumours With A Rapamycin Derivative | NOVARTIS AG |
22 Dec, 2017
(Expiration: Feb, 2022)
|
ETHYPHARM
(and 1 more)
| |
| EP2776129B2 | Calcimimetics And Methods For Their Use | KAI PHARMACEUTICALS |
22 Dec, 2017
|
HEXAL SANDOZ
| |
| EP2460817B1 | Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions | BOEHRINGER INGELHEIM VETMEDICA INC |
22 Dec, 2017
(Expiration: Dec, 2025)
|
INTERVET
| |
| EP3045471B1 | Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation | FERRING BV |
22 Dec, 2017
(Expiration: Apr, 2029)
|
MERCK SERONO
| |
| EP2558116B2 | Agent For Locally Treating Cervical Dysplasias | GENERAL VECTORS |
21 Dec, 2017
|
GLAXOSMITHKLINE BIOLOGICALS
| |
| EP2493498B1 | Purification Of Staphylococcus Aureus Type 5 And Type 8 Capsular Saccharides | GLAXOSMITHKLINE BIOLOGICALS SA |
21 Dec, 2017
(Expiration: Nov, 2030)
|
PFIZER
| |
| EP2532676B1 | Protease-Regulated Antibody | BAYER PHARMA |
21 Dec, 2017
|
WHITE
| |
| EP3050556B1 | Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate | TEVA PHARMACEUTICAL INDUSTRIES LTD |
21 Dec, 2017
(Expiration: Sep, 2035)
|
WITTKOPP
(and 1 more)
| |
| EP2575770B1 | Process For Making Dry And Stable Hemostatic Compositions | BAXTER |
20 Dec, 2017
|
FERROSAN MEDICAL DEVICES
(and 1 more)
| |
| EP2637664B1 | Compositions And Methods Of Treating Pulmonary Hypertension | GILEAD SCIENCES INC |
20 Dec, 2017
(Expiration: Oct, 2031)
|
STADA ARZNEIMITTEL
(and 5 more)
| |
| EP1731152B1 | Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine | EURO CELTIQUE SA |
20 Dec, 2017
(Expiration: Feb, 2018)
|
TESA LABTEC
(and 2 more)
| |
| EP2477611B1 | (Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved Stability | SANOFI SA |
19 Dec, 2017
(Expiration: Sep, 2030)
|
COOKE
(and 2 more)
| |
| EP1845956B1 | Break-Resistant Delayed-Release Forms Of Administration | GRUENENTHAL GMBH |
19 Dec, 2017
(Expiration: Feb, 2026)
|
G L PHARMA
| |
| EP3053571B1 | Process For The Preparation Of A Particulate Dental Filler Composition | DENTSPLY DETREY |
19 Dec, 2017
|
KULZER
| |
| EP2261184B8 | Lithium Silicate Glass Ceramic | IVOCLAR VIVADENT |
19 Dec, 2017
|
VITA ZAHNFABRIK H RAUTER
| |
| EP2680880B2 | Vaccination In Newborns And Infants | CUREVAC |
18 Dec, 2017
|
STRAWMAN
| |
| EP2680881B1 | Vaccination In Elderly Patients | CUREVAC AG |
18 Dec, 2017
(Expiration: Feb, 2032)
|
STRAWMAN
| |
| EP2056832B1 | Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin Derivate | ASTRAZENECA AB |
18 Dec, 2017
(Expiration: Aug, 2027)
|
WITTKOPP
(and 2 more)
| |
| EP2346475B2 | Personal Care Compositions Providing Enhanced Cooling Sensation | THE PROCTER & GAMBLE |
15 Dec, 2017
|
COLGATE PALMOLIVE
| |
| EP1798285B1 | Methods And Medicament For Inhibition The Expression Of A Defined Gene | ALNYLAM EUROPE AG |
15 Dec, 2017
(Expiration: Jan, 2020)
|
SILENCE THERAPEUTICS
| |
| EP2519231B1 | Treatment Of Disease With Proteasome Inhibitors Background Of The Invention | JANSSEN PHARMACEUTICA NV |
14 Dec, 2017
(Expiration: Oct, 2030)
|
ACCORD HEALTHCARE
| |
| EP1976558B1 | Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs | BOEHRINGER INGELHEIM VETMEDICA INC |
14 Dec, 2017
(Expiration: Dec, 2026)
|
ELI LILLY
| |
| EP2410981B2 | Dry Powder Formulations And Methods For Treating Pulmonary Diseases | PULMATRIX OPERATING |
12 Dec, 2017
|
TEVA UK
| |
| EP2694267B2 | Continuous Process Of Making An Article Of Dissolution Upon Use To Deliver Surfactants | THE PROCTER & GAMBLE |
11 Dec, 2017
|
HENKEL
| |
| EP2421504B2 | Paediatric Solutions Comprising A Beta-Blocker | PIERRE FABRE DERMATOLOGIE |
08 Dec, 2017
|
AECHTER
| |
| EP2044947B1 | Compositions And Methods | OXFORD UNIVERSITY INNOVATION LTD |
08 Dec, 2017
(Expiration: Dec, 2027)
|
IMUTEX
| |
| EP2688877B1 | Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof | TEVA PHARMACEUTICALS |
08 Dec, 2017
|
MACKERT
| |
| EP2988756B2 | Contrast Medium Formulation And Related Preparation Method | GUERBET |
08 Dec, 2017
|
MASCHIO & SOAMES
| |
| EP2627676B1 | Novel Cellulose Ethers And Their Use | DOW |
08 Dec, 2017
|
SHIN ETSU CHEMICAL
| |
| EP2872497B2 | Chromanyl Derivatives For Treating Mitochondrial Disease | KHONDRION |
08 Dec, 2017
|
SULFATEQ
| |
| EP2723319B1 | Composition Comprising An Onion Extract And Liposomes | MERZ PHARMA |
07 Dec, 2017
|
FARCO PHARMA
| |
| EP2637670B2 | Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains | AMGEN RESEARCH MUNICH |
07 Dec, 2017
|
LINDIS BIOTECH
(and 1 more)
| |
| EP2668175B2 | Process | SHIELD TX UK |
07 Dec, 2017
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2381797B2 | Animal Feed Additive And Animal Feed Comprising Alkyl Esters Of Medium Chain Fatty Acids, And Their Use In Animal Feed | NUTRECO NEDERLAND |
06 Dec, 2017
|
NUTRITION SCIENCES
| |
| EP2347770B2 | Process For Producing An Injectable Pharmaceutical Preparation | VERGELL MEDICAL |
06 Dec, 2017
|
VOSSIUS & PARTNER PATENTANWLTE RECHTSANWLTE MBB
| |
| EP2996777B1 | Oral Care Compositions | UNILEVER |
01 Dec, 2017
|
COLGATE PALMOLIVE
| |
| EP2445911B1 | 5-Phenyl-[1,2,4]Triazolo[1,5-A]Pyridin-2-Yl Carboxamides As Jak Inhibitors | GALAPAGOS |
01 Dec, 2017
|
GENERICS UK
| |
| EP2040683B2 | Pharmaceutical Composition Containing A Tetrahydrofolic Acid | BAYER |
01 Dec, 2017
|
LABORATORIOS LON FARMA
| |
| EP2717845B1 | Styling Agents Having Maximum Hold | HENKEL |
01 Dec, 2017
|
LOREAL
| |
| EP2496700B1 | Nucleic Acid-Containing Lipid Particles And Related Methods | UNIVERSITY OF BRITISH COLUMBIA |
01 Dec, 2017
(Expiration: Nov, 2030)
|
MERCK SHARP & DOHME
(and 1 more)
| |
| EP2646470B1 | Low Affinity Blood Brain Barrier Receptor Antibodies And Uses Therefor | F HOFFMANN LA ROCHE AG |
01 Dec, 2017
(Expiration: Nov, 2031)
|
PFIZER
(and 2 more)
| |
| EP2345433B1 | Tissue Plug | 3D MATRIX LTD |
30 Nov, 2017
(Expiration: Oct, 2029)
|
POTTER CLARKSON
| |
| EP2624859B1 | Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders | MEDIMMUNE LTD |
30 Nov, 2017
(Expiration: Sep, 2031)
|
STRAWMAN
| |
| EP2791163B1 | Process For T Cell Expansion | ALLOVIR |
30 Nov, 2017
|
STRAWMAN
| |
| EP2792373B1 | Ultra High Molecular Weight Polyethylene Articles And Methods Of Forming Ultra High Molecular Weight Polyethylene Articles | ZIMMER GMBH |
29 Nov, 2017
(Expiration: Aug, 2025)
|
AESCULAP
| |
| EP2432454B1 | Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors | NEURODERM |
29 Nov, 2017
|
TEVA
| |
| EP2448548B1 | Methods For Improving The Appearance Of Hyperpigmented Spot(S) With Multiple Actives | PROCTER AND GAMBLE CO |
29 Nov, 2017
(Expiration: Jul, 2030)
|
UNILEVER
| |
| EP2266958B1 | Antiviral Agent | SHIONOGI AND CO LTD |
28 Nov, 2017
(Expiration: Aug, 2022)
|
MERCK
| |
| EP2301961B9 | Sclerostin Epitopes | AMGEN |
22 Nov, 2017
|
JAMES POOLE
| |
| EP2425824B1 | Pharmaceutical Preparation Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
09 Nov, 2017
(Expiration: Apr, 2023)
|
G L PHARMA
(and 10 more)
| |
| EP2258847B2 | Futher Novel Forms Of Interfering Rna Molecules | SILENCE THERAPEUTICS |
19 Oct, 2017
|
ALNYLAM PHARMACEUTICALS
(and 2 more)
| |
| EP2949335B1 | Low Frequency Glatiramer Acetate Therapy | YEDA RESEARCH AND DEVELOPMENT CO LTD |
03 Oct, 2017
(Expiration: Aug, 2030)
|
GENERICS UK TRADING MYLAN
(and 5 more)
| |
| EP2841431B2 | Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same | OTSUKA PHARMACEUTICAL |
28 Sep, 2017
|
GEORG KALHAMMERSTEPHAN TEIPEL
| |
| EP2425821B1 | Pharmaceutical Preparation Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
11 May, 2017
(Expiration: Apr, 2023)
|
DEVELCO PHARMA SCHWEIZ
(and 10 more)
|